Drugs / GTU-MultiHIV B clade vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01130376 | Sep 2009 → Oct 2011 | HIV infectious disease | Imperial College London | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GTU-MultiHIV B clade vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01130376 ↗ |
| Modality | Vaccine | “a novel DNA vaccine boosted with immune based therapy” NCT01130376 ↗ |